Literature DB >> 30836229

Possible donor-dependent differences in efficacy of fresh frozen plasma for treatment of ACE inhibitor-induced angioedema.

Sara X Chen1, Daniela Hermelin2, Steven J Weintraub3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30836229      PMCID： PMC6612440          DOI： 10.1016/j.jaip.2019.02.027

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  9 in total

1.  Angiotensin-converting enzyme inhibitor-induced angioedema worsened with fresh frozen plasma.

Authors:  Omoyemi Adebayo; R Gentry Wilkerson
Journal:  Am J Emerg Med       Date:  2016-06-28       Impact factor: 2.469

2.  Nonadherence with angiotensin-converting enzyme inhibitor therapy: a comparison of different ways of measuring it in patients with chronic heart failure.

Authors:  A D Struthers; R MacFadyen; C Fraser; J Robson; J J Morton; C Junot; E Ezan
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

3.  Plasma bradykinin in angio-oedema.

Authors:  J Nussberger; M Cugno; C Amstutz; M Cicardi; A Pellacani; A Agostoni
Journal:  Lancet       Date:  1998-06-06       Impact factor: 79.321

4.  Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema.

Authors:  Brittany T Straka; Claudia E Ramirez; James B Byrd; Elizabeth Stone; Alencia Woodard-Grice; Hui Nian; Chang Yu; Aleena Banerji; Nancy J Brown
Journal:  J Allergy Clin Immunol       Date:  2016-11-29       Impact factor: 10.793

5.  Endogenous bradykinin and B1-B5 during angiotensin-converting enzyme inhibitor-associated angioedema.

Authors:  Scott A Hubers; Kevin Kohm; Shouzuo Wei; Chang Yu; Hui Nian; Ryan Grabert; Daniel J Sexton; Nancy J Brown
Journal:  J Allergy Clin Immunol       Date:  2018-07-21       Impact factor: 10.793

6.  Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin.

Authors:  Giuseppe Molinaro; Massimo Cugno; Mélissa Perez; Yves Lepage; Nicole Gervais; Angelo Agostoni; Albert Adam
Journal:  J Pharmacol Exp Ther       Date:  2002-10       Impact factor: 4.030

Review 7.  Novel Therapies for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review of Current Evidence.

Authors:  Heidi M Riha; Bryant B Summers; Jessica V Rivera; Megan A Van Berkel
Journal:  J Emerg Med       Date:  2017-09-20       Impact factor: 1.484

8.  Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema.

Authors:  Richard Sinert; Phillip Levy; Jonathan A Bernstein; Richard Body; Marco L A Sivilotti; Joseph Moellman; Jennifer Schranz; Jovanna Baptista; Alan Kimura; Wolfram Nothaft
Journal:  J Allergy Clin Immunol Pract       Date:  2017-05-25

9.  Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease.

Authors:  Lidia Anguiano; Marta Riera; Julio Pascual; José Manuel Valdivielso; Clara Barrios; Angels Betriu; Sergi Mojal; Elvira Fernández; María José Soler
Journal:  Nephrol Dial Transplant       Date:  2015-03-26       Impact factor: 5.992
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.